← All Supernus Pharmaceuticals, INC filings

Supernus Pharmaceuticals, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
SUPN
Supernus Pharmaceuticals, INC
DEF: Supernus 2026 Annual Meeting Proxy Statement
Supernus Pharmaceuticals schedules its 2026 Annual Meeting of Stockholders for June 18, 2026, to address director elections, executive compensation, and equity plan expansion.
NASDAQ
SUPN
Supernus Pharmaceuticals, INC
DEFA14A: Supernus Pharmaceuticals Sets Date for Annual Stockholders Meeting
Supernus Pharmaceuticals will hold its annual stockholders meeting virtually on June 16, 2025, to vote on director elections, executive compensation, auditor ratification, and a stockholder proposal.
NASDAQ
SUPN
Supernus Pharmaceuticals, INC
DEF 14A: Supernus Pharmaceuticals Sets Date for 2025 Annual Stockholders Meeting
Supernus Pharmaceuticals will hold its 2025 Annual Meeting of Stockholders virtually on June 16, 2025, to vote on director elections, executive compensation, and the ratification of its independent auditor.
NASDAQ
SUPN
Supernus Pharmaceuticals, INC
DEFA14A: Supernus Pharmaceuticals Sets Date for Annual Stockholders Meeting, Outlines Key Proposals
Supernus Pharmaceuticals will hold its annual stockholders meeting virtually on June 14, 2024, to vote on director elections, executive compensation, auditor ratification, and an amendment to the equity incentive plan.
NASDAQ
SUPN
Supernus Pharmaceuticals, INC
DEF 14A: Supernus Pharmaceuticals Sets Date for 2024 Annual Stockholders Meeting
Supernus Pharmaceuticals will hold its 2024 Annual Meeting of Stockholders virtually on June 14, 2024, to vote on director elections, executive compensation, auditor ratification, and an equity incentive plan amendment.